Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2023 Earnings Call Transcript

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2023 Earnings Call Transcript February 22, 2024 Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.07 EPS, expectations were $0.2. Amylyx Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. […]

Related Keywords

Phoenix ,Arizona ,United States ,Canada ,America ,Josh Cohen ,Linda Arsenault ,Camille Bedrosian ,Geoff Meacham ,Washington University ,Most Valuable Luxury Companies ,Chief Medical Officer ,New England Journal ,Rating Scale Revised ,Progressive Supranuclear Palsy ,Chief Human Resources ,Valuable Luxury Companies ,Back Out ,Amylyx Pharmaceuticals ,Neurodegenerative Diseases ,Living With Als ,Fourth Quarter ,Lindsey Allen ,Relyvrio ,